BRPI0923045A2 - "derivados de 6-ciclo amino-2-tienil-3(piridin-4-il)imidazo{1,2-b]-piridazina e 6-ciclo amino-2-furanil-3-(piridin-4-il)imidazo[1,2-b]-piridazina,processo de preparação e aplicação terapêutica dos mesmos". - Google Patents

"derivados de 6-ciclo amino-2-tienil-3(piridin-4-il)imidazo{1,2-b]-piridazina e 6-ciclo amino-2-furanil-3-(piridin-4-il)imidazo[1,2-b]-piridazina,processo de preparação e aplicação terapêutica dos mesmos".

Info

Publication number
BRPI0923045A2
BRPI0923045A2 BRPI0923045A BRPI0923045A BRPI0923045A2 BR PI0923045 A2 BRPI0923045 A2 BR PI0923045A2 BR PI0923045 A BRPI0923045 A BR PI0923045A BR PI0923045 A BRPI0923045 A BR PI0923045A BR PI0923045 A2 BRPI0923045 A2 BR PI0923045A2
Authority
BR
Brazil
Prior art keywords
cycloamino
pyridazine
pyridin
imidazo
furanyl
Prior art date
Application number
BRPI0923045A
Other languages
English (en)
Inventor
Alain Gueiffier
Cécile Enguehard-Gueiffier
Frederic Puech
Mireille Sevrin
Pascal George
Qiuxia Zhao
Yulin Chiang
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of BRPI0923045A2 publication Critical patent/BRPI0923045A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
BRPI0923045A 2008-12-19 2009-12-17 "derivados de 6-ciclo amino-2-tienil-3(piridin-4-il)imidazo{1,2-b]-piridazina e 6-ciclo amino-2-furanil-3-(piridin-4-il)imidazo[1,2-b]-piridazina,processo de preparação e aplicação terapêutica dos mesmos". BRPI0923045A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0807260A FR2940285A1 (fr) 2008-12-19 2008-12-19 Derives de 6-cycloamino-2-thienyl-3-(pyridin-4-yl)imidazo °1,2-b!-pyridazine et 6-cycloamino-2-furanyl-3- (pyridin-4-yl)imidazo°1,2-b!-pyridazine, leur preparation et leur application en therapeutique
US13965408P 2008-12-22 2008-12-22
PCT/FR2009/052592 WO2010070237A1 (fr) 2008-12-19 2009-12-17 DÉRIVÉS DE 6-CYCLOAMINO-2-THIENYL-3-(PYRIDIN-4-YL)IMIDAZO[1,2-b]-PYRIDAZINE ET 6-CYCLOAMINO-2-FURANYL-3-(PYRIDIN-4-YL)IMIDAZO[1,2-b]-PYRIDAZINE, LEUR PRÉPARATION ET LEUR APPLICATION EN THÉRAPEUTIQUE

Publications (1)

Publication Number Publication Date
BRPI0923045A2 true BRPI0923045A2 (pt) 2015-12-15

Family

ID=40848280

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0923045A BRPI0923045A2 (pt) 2008-12-19 2009-12-17 "derivados de 6-ciclo amino-2-tienil-3(piridin-4-il)imidazo{1,2-b]-piridazina e 6-ciclo amino-2-furanil-3-(piridin-4-il)imidazo[1,2-b]-piridazina,processo de preparação e aplicação terapêutica dos mesmos".

Country Status (18)

Country Link
US (1) US20130190314A1 (pt)
EP (1) EP2398802A1 (pt)
JP (1) JP2012512852A (pt)
KR (1) KR20110108332A (pt)
CN (1) CN102256979A (pt)
AR (1) AR074795A1 (pt)
AU (1) AU2009329426A1 (pt)
BR (1) BRPI0923045A2 (pt)
CA (1) CA2747359A1 (pt)
FR (1) FR2940285A1 (pt)
IL (1) IL213581A0 (pt)
MX (1) MX2011006598A (pt)
PA (1) PA8854501A1 (pt)
RU (1) RU2011129828A (pt)
SG (1) SG172180A1 (pt)
TW (1) TW201028419A (pt)
UY (1) UY32348A (pt)
WO (1) WO2010070237A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2782601C (en) 2009-12-18 2015-07-21 Mitsubishi Tanabe Pharma Corporation Novel antiplatelet agent
US9556179B2 (en) 2012-12-21 2017-01-31 Bristol-Myers Squibb Company Substituted imidazoles as casein kinase 1 D/E inhibitors
CN104837844B (zh) * 2012-12-21 2017-08-29 百时美施贵宝公司 作为酪蛋白激酶1 d/e抑制剂的吡唑取代的咪唑并哌嗪
AU2022367432A1 (en) 2021-10-14 2024-05-02 Incyte Corporation Quinoline compounds as inhibitors of kras
WO2023147015A1 (en) * 2022-01-27 2023-08-03 The Broad Institute, Inc. Substituted heterocyclic csnk1 inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001333A1 (en) * 1987-08-07 1989-02-23 The Australian National University IMIDAZO[1,2-b]PYRIDAZINES
WO2005061498A1 (en) 2003-12-11 2005-07-07 Aventis Pharmaceuticals Inc. Substituted 1h-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase i epsilon
WO2005107760A1 (en) * 2004-04-30 2005-11-17 Irm Llc Compounds and compositions as inducers of keratinocyte differentiation
WO2006070943A1 (ja) * 2004-12-28 2006-07-06 Takeda Pharmaceutical Company Limited 縮合イミダゾール化合物およびその用途
GB0515026D0 (en) * 2005-07-21 2005-08-31 Novartis Ag Organic compounds
DE102005042742A1 (de) * 2005-09-02 2007-03-08 Schering Ag Substituierte Imidazo[1,2b]pyridazine als Kinase-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel
US7750000B2 (en) * 2005-09-02 2010-07-06 Bayer Schering Pharma Ag Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicaments
FR2918061B1 (fr) * 2007-06-28 2010-10-22 Sanofi Aventis Derives de 6-cycloamino-3-(pyridin-4-yl)imidazo°1,2-b!- pyridazine,leur preparation et leur application en therapeutique.
FR2918986B1 (fr) * 2007-07-19 2009-09-04 Sanofi Aventis Sa Derives de 6-cycloamino-3-(pyridazin-4-yl)imidazo[1,2-b]- pyridazine, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
PA8854501A1 (es) 2010-07-27
KR20110108332A (ko) 2011-10-05
FR2940285A1 (fr) 2010-06-25
MX2011006598A (es) 2011-10-12
SG172180A1 (en) 2011-07-28
TW201028419A (en) 2010-08-01
CN102256979A (zh) 2011-11-23
IL213581A0 (en) 2011-07-31
UY32348A (es) 2010-07-30
AR074795A1 (es) 2011-02-09
WO2010070237A1 (fr) 2010-06-24
CA2747359A1 (fr) 2010-06-24
EP2398802A1 (fr) 2011-12-28
AU2009329426A1 (en) 2011-07-07
JP2012512852A (ja) 2012-06-07
RU2011129828A (ru) 2013-01-27
US20130190314A1 (en) 2013-07-25

Similar Documents

Publication Publication Date Title
FR2918986B1 (fr) Derives de 6-cycloamino-3-(pyridazin-4-yl)imidazo[1,2-b]- pyridazine, leur preparation et leur application en therapeutique
BRPI0917939A2 (pt) derivados de 2-alquil-6-cicloamino-3-(piridin-4-il) imidazo[1,2-b]-piridazina, preparação dos mesmos e aplicação dos mesmos em terapia
ZA200909186B (en) 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives,preparation thereof and therapeutic use thereof
DK2069342T3 (da) Derivater af 2-aryl-6-phenyl-imidazol[1,2-A]pyridiner, fremstilling og terapeutisk anvendelse deraf
WO2009108730A3 (en) Forms of rifaximin and uses thereof
MX2010013020A (es) Metodos y composiciones para trastornos del sueño y otros trastornos.
WO2008121687A3 (en) Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
IL208247A0 (en) Polysubstituted derivatives of 6-heteroaryl-imidazo[1,2-a]pyridines, and preparation and therapeutic use thereof
MX2009006162A (es) Compuestos y metodos para modulacion de cinasas, e indicaciones para ello.
NO20053920D0 (no) Preparat for og behandling av demyelineringssykdommer og paralyse ved administrering av remyelineringsmidler.
ZA201005602B (en) Imidazo [1,2-b]pyridazine derivatives for the treatment of c-met tyrosine kinase mediated disease
IL208248A0 (en) Polysubstituted derivatives of 2-aryl-6-phenyl-imidizo[1,2-a]pyridines, and preparation and therapeutic use thereof
IL191160A (en) Use of pyrido [3,2- b] pyrazine-6-yl urine urine for the preparation of drugs to treat diseases caused by the enzyme pi3k inhibition.
MX277822B (es) Derivados de urea de tropano, su preparacion y su aplicacion terapeutica.
EA200800992A1 (ru) 2-амино-7,8-дигидро-6н-пиридо[4,3-d]пиримидин-5-оны, способ их получения, способ терапии с их помощью, компонент композиции и композиция на их основе, 2,4-диоксопиперидиновые соединения для их получения
WO2009145456A3 (ko) 헤테로사이클 유도체
WO2008082887A3 (en) Inhibitors of poly(adp-ribose)polymerase
BRPI0923045A2 (pt) "derivados de 6-ciclo amino-2-tienil-3(piridin-4-il)imidazo{1,2-b]-piridazina e 6-ciclo amino-2-furanil-3-(piridin-4-il)imidazo[1,2-b]-piridazina,processo de preparação e aplicação terapêutica dos mesmos".
FR2925902B1 (fr) DERIVES D'IMIDAZO°1,2-a!PYRIDINE-2-CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
WO2008157563A3 (en) Deuterium-enriched clopidogrel
DK2185561T3 (da) Derivater af 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6-carboxamid og 2,3,4,5-tetrahydroprrolo(1,2-a)-diazepin-7-carboxamid, fremstilling deraf og terapeutisk anvendelse deraf
BRPI0821992A2 (pt) Derivados de n-heterocíclico-imidazo[1,2-a]piridina-2-carboxamida s, respectivo preparo e respectiva aplicação em terapêutica
BRPI0923182A2 (pt) derivados de 6-cicloamino-2,3-di-piridinil-imidazo[1,2-b]piridazina, o respectivo preparo e a respectivo preparo e a respectiva aplicação terapêutica
IL198481A0 (en) Pyrrole derivatives, preparation use of the same in therapy
BRPI0922760A2 (pt) derivados de 6-ciclo amino -3-(1h-pirrolo [2,3-b] piridin -4-il) imidazo [1,2-b]- piridazina, o respectivo preparo e a respectiva aplicação em terapêutica

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]